Forum

La Cuisine Espace MicroCaps - Discussions ouvertes

Oui mais Ackroo ne génère pas de revenus en fonction du volume d’affaires d’un commerçant, à part la portion cartes physiques en plastique qui devrait réduire j’imagine.

Pour reprendre ton exemple, si la seule entrée d’argent de ton amie c’est maintenant les cartes cadeaux, et que son programme de cartes cadeaux lui coûte seulement 80$/mois, pourquoi elle couperait ce service?

Cela dit, c’est certainement possible qu’il y ait des retards de paiement. Le plus gros risque à moyen/long terme ce serait qu’il y ait des fermetures massives de PME (c’est-à-dire des clients d’Ackroo qui font faillite).

Peut-être que ça peut intéresser certains d’entre vous:

AnalytixInsight Helps Investors Through COVID-19 Pandemic by Offering Free Access to its CapitalCube Financial Analytics Platform

2 « J'aime »

C’et avec ce SAAS que t’avais généré les pamphlets/sommaires d’une page des entreprises qui présentaient à la dernière réunion au beer market?

Oui c’était eux!

Merci je me suis inscrit à la version temporairement gratuite, je vais essayer de trouver l’option de générer les sommaires d’une page, ils étaient bien utiles

Il devrait tout de même y avoir une correlation très forte.

Bon point. Elle n’utilise pas de logiciel pour ça, donc ce n’est peut-être pas tout à fait applicable à Ackroo. Par contre, la dernière stats que j’ai vue mentionnait que les restaurants ont en moyenne 3 semaines de cashflows devant eux.

De mon côté on a coupé dans à peu près tous nos subscribes, mêmes ceux essentiels comme Zoho, Dropbox, Adobe et Airtable (1-2 compte chaque au lieu d’un pour chaque membre de l’équipe), même si on est n’est pas en danger existentiel.

Je ne veux pas sonner encore plus pessimiste; je trouvais pertinent de rappeler que les résultats de Q2 (et même Q3) de beaucoup d’entreprises vont être à la baisse.

1 « J'aime »

@raf pour le cocktail 5à7, ils m’avaient fait une version personnalisée avec les données que j’avais demandé. Donc tu ne seras pas en mesure de retrouver exactement la même chose sur leur site, mais tu pourras probablement quand même trouver beaucoup d’information utile!

1 « J'aime »

Je vais m’informer, mais Ackroo n’a pas une facturation par “siège”.

Ils veulent développer le self-serve, mais la plupart de leurs revenus sont encore facturés comme un legacy SaaS. Contrat de 12-36 mois avec paiements mensuels donc leur base de clients c’est plus dans la moyenne entreprise (10-150) emplacements que la petite.

J’anticipe des problèmes de collection et quelques faillites, mais la compagnie devrait passer à travers. Leur prêteur court terme a approuvé une augmentation de la LOC à 800k et possibilité de 1.6M si la crise se prolonge.

Il y a encore 1M de pré-approuvé avec la BDC pour une acquisition. Il y aura possiblement des opportunités chez des petits joueurs en difficulté.

Ackroo n’a pas un super bilan mais au moins le prêteur c’est la BDC. L’opportunité reste intéressante à long terme mais le risque a clairement augmenté.

Not your sexy SaaS next door at a discount.

1 « J'aime »

Sur le MicroCapClub:

From Steve

Our LOC increase went into effect on April 1st (increased to $1.6M) providing us lots of wiggle room. We have other additional capital plans (non equity related) as well that we are pursuing to provide lots of cover.

For us a 3rd of our business is petroleum and gas stations are all open right now so 1/3 of our revenue and cash will keep coming in. We also have some pharmacies and many QSR and TSR that are doing take-out/delivery and so we do expect them to keep paying as well. Our wet finger is a plan to cover half of the revenue from a deferred payment perspective and so based on that assumption and our current costs (HR and Other) we have a plan that will take us into 2021 if necessary. If for some crazy reason it extended beyond 2021 then we would do re-structuring of our own (staff reductions) assuming we didn’t grow our revenue. Keep in mind however we will most likely get M&A done even during this weird time and so there will be growth there to help keep things moving forward and allow us to retain all staff. We have no plans around doing layoffs in 2020 and believe we can manage our business and our cash flow to do so.

3 « J'aime »

Voici un récapitulatif d’une conversation sur le COVID-19 avec mon ami qui est pharmacien clinicien dans un hôpital de l’Ontario. Mes notes sont une perspective intéressante sur la façon dont ce virus pourrait affecter notre jour à jour pour les 12 à 18 prochains mois. L’esprit de partager ces informations c’est parce que je pense que vous pouver appliquer son point de vue long terme à vos thèses d’investissements et de comprender comment cela pourrait affecter vos microcaps. Désolé, je ne voulais pas tout traduire.

Respiratory tract:
It is his opinion that this is one of the biggest medical areas where the scientific community has failed to come up with a cure to eliminate or even properly treat viral respiratory infections. There is no drug or vaccine that properly target or helps fight off a virus that attacks respiratory tract. Many drugs have been created (Tamiflu/Oseltamivir etc.) but they don’t effectively work to eliminate the infection. Ex. Tamiflu may suppress the symptoms for day 1 and show limited effects on day 2 & thereafter. In 100yrs of medical advancements, there is NO miracle respiratory “go to” cure for viral infections.

Upper Respiratory Viral Infections (most common): Associated with the many symptoms of the common cold. Most the time contracted from daycare (kids), work or at Christmas when many people come into close contact. There is no cure, per see, and your body must fight it off naturally. Tylenol/Advil is the most common medication taken to alleviate some the symptoms (fever) but does not reduce the time it takes the body to fight off the infection.
Lower Respiratory Viral infections (lungs): The viral infections of the lower respiratory tract are a lot more serious because they can create an ideal environment to allow for a secondary bacterial infection to breakout in the lungs such as bronchitis, pneumonia, tuberculosis. In other words, a virus can trigger the lung infection directly (without affecting the bacterial level) or triggers the environment to allow the bad bacterial to cause the disease. COVID-19 is known to cause pneumonia, it is believed to be in a direct relationship to trigger pneumonia, therefore, treating pneumonia with medication that targets against bacteria will not work. The ONLY solution to treat COVID-19 induced pneumonia is using a ventilator to pump oxygen in the lungs and let the body fight it off over many days!

*COVID-19: SARS has been around for 17yrs and we still do not have a vaccine or medication to deal with this virus. It has mutated many times over 17yrs and making an effective vaccine has been unsuccessful for mass distribution. COVID-19 is part of the SARS family and may be of the “progeny” of the original SARS virus. He does not expect any “new” medication or vaccine to come out in the next 12months. *

Vaccine: takes 12+ months and the “industry” was not able to create an original SARS vaccine in time from the initial SARS breakout in the early 2000’s. He expects the SARS form of COVID-19 to keep mutating and making an effective vaccine for mass immunization extremely difficult. If something comes out, he hypotheses that it will have limited desired immunity effects, the industry will keep having to inoculate the population with booster shots every year with mixed results. Think of the free “flu” vaccine that we are eligible to get every year; does it really work? How many people you know still get sick? He expects the same mixed results with a COVID-19 vaccine. It will most like NOT eliminate the virus from the planet.

New medication: not hopeful because pneumonia has been around for 100yrs+ and the treatments do not target the inflammation directly which constrict the air vessels, the medication targets the bacteria. The best treatment would be a dual/combo drug that targets the inflammation & bacterial. Why haven’t they found this drug that target inflammation in the lungs yet? If a drug in the pipeline it will take 12+ month. Pneumonia triggered by COVID-19 needs the “anti-inflammation” drug which doesn’t exist, so ventilators are the only option. Which is why the ONLY immediate way a country can handle COVID-19 is to “Flatten the Curve”.

*Flattening the curve: based on the information he shared about the current developments in the vaccine and medication strategy to eliminate COVID-19 - his belief that the only viable option for governments is to “flatten the curve” over the next 12month if not longer so that we may gain “herd immunity”. The top medical officials know this and want to sustain a low infection rate so that hospitals are not overwhelmed, and people are not dying. The Provincial infection rates will stabilize in the next months and we will then evaluate the impact on our hospitals’ capacity when the curve is flat. From a disease management perspective (and mentioned above) there is no medication or vaccine that will be ready in the short term (when we flatten the curve) so they will not all business/travel to go back to normal because COVID-19 infections will explode again! It only takes 1 person to start the spread again (12day incubation period)! He expects that these “self-isolation” measures will be in place for a long time while we wait for a cure (if any). The citizens need to keep slowly getting infected over time; the goal is not to stop the infection rate - it is to manage the infection rate to keep hospitals at capacity. It is important to note that 80% will not need to be in a hospital if infected. He expects the government to relax a small set of “non-essential” services (school, restaurants, bars) and keep monitoring the hospitalization rate to make sure we have enough ventilators available. If the infections start to spike again (especially in the elderly population), expect to go back to lock down of certain “services” and social distancing. We will not be going back to normal anytime soon until most the populate contracts COVID-19 develops immunity. *
In his opinion, the biggest immediate impact to help us get “back to normal” are: (because we need to assume there will be no cure in the next 12-18 months)
1. Heard immunity - slow and steady (assume that a vaccine will not be 100% effective in 12month because of mutations)
a. All “Services” stay limited for a very long time this is the new “normal” – get ready
b. It will take >1yr to safely let the virus infect everyone and not overwhelm the hospital system.
2. Government purchases thousands of ventilators to allows for a higher “controlled” infection rate.
a. Just a thought: we could even see controlled infections in certain subset of our population to increase immunity in our population.
3. Open non-essential services 1-2days week to help with herd immunity
4. The people get fed up and start socializing in public – the spread increase over summer activities.
5. Government feels the pressure (economic and financial)- lets everyone go back to normal and we see a spike in infections and deaths. Back to lockdown!
6. 12-18months later - hopefully the medical community has a solution.
7. Countries that did not control the spread of COVID-19 will have the most death but will also return to normal once heard immunity is acquired. 2 paths to immunity to going back to normal (Slow spread vs mass deaf)…

Cette information est son opinion du point de vue d’un pharmacien clinicien (que j’ai noté dans mes mots), je ne suis pas expert en la matière. J’ai pensé que ce serait utile de partager pour intégrer dans votre hypothèse / thèse d’investissement à long terme.

Plus de confirmation - On a un ami de famille qui est député au gouvernement provincial et il a confirmé que notre future - prochains 12mois (si on n’a pas de solution médicale) va être avec des services limités et isolation sociale pour pas déborder le system de santé. Notre future va être pénible! J’ai peur pour l’économie!

4 « J'aime »

Ça donne froid dans le dos!

C’était plus une idée provocante pour répondre à ma question « what can be donne to speed up back to normal in under 12months »? Un giant project de science et éthique pour rendre La population immunisé au virus. Est-ce qu’on infecte les personnes plus à risque ou les personnes moins à risque pour accélérer l’immunisation de la population? Les possibilités que le government essaye ça sont très bas…

Ça donne froid dans le dos!

Pourquoi?

Selon moi c’est la seule solution. Le ratio de gens qui se rendent en soins hospitaliers dans certains « subsets » est tellement plus faible qu’avec les personnes agées par exemple que ca te permet d’immuniser une plus grand partie de la population le plus rapidement possible.

Personnellement, je n’ai aucun problème a ce que moi, ma conjointe et nos 2 enfants soient infectés pour aller dans cette voie.

Si ce n’était pas aussi mal vu, j’aurais déja chercher quelqu’un pour « m’infecter ».

Moi, me garder enfermé pendant 3 mois pour ensuite avoir autant de chance de la pogner 1 semaine après avoir recommencé à sortir, ca m’allume pas ben ben!

1 « J'aime »

Esprit de partager cette information et la conclusion que je voulais faire, c’est qu’on va vivre avec capacité réduite pour très longtemps. Quelles microcaps vont survivent pour 12-18mois? Est-ce que c’est le temps de modifier votre portfolio?

Bon article de Steve Saretski de ce matin sur son blog:

Happy Monday Morning!

Canadian households are buckling in for what is likely to be a turbulent ride. According to the Canadian Bankers Association, there have now been nearly 500,000 mortgage deferrals completed or in the process of completing since the program was announced two weeks ago. That’s nearly 10% of all mortgages outstanding. That number will surely climb in the weeks ahead, placing further strain on Canadian banks.

OSFI, the banking regulator, is now looking at slashing the stability buffer once again, potentially even removing it to free up liquidity. « We’re monitoring the situation closely and we stand ready to take further steps. For example, on the capital side, we released about half of the stability buffer that we’ve imposed on the major banks, and we’re monitoring that, and we’re prepared to release some or all of what remains, if need be. » noted Jeremy Rudin, the Superintendent of Financial Institutions.

Meanwhile, The Bank of Canada began its first-ever foray into quantitative easing this past week, with the purchase of C$1.0 billion in government bonds. Their balance sheet instantly inflated to new, unprecedented highs and will only balloon further with their pledge to devour $5B of Government bonds each week until a recovery is « well underway. »

Suffice to say a recovery in Canada appears further away than most countries given the enormous build-up in household debt. Empirical evidence has shown recessions tend to be considerably deeper and the recovery much slower when the preceding boom saw a strong expansion of mortgage debt.

As noted in a recent piece from Veritas Investment Research, we can no longer count on the consumer: Household spending accounts for ~68.5% of U.S. GDP and ~63.6% globally based on World Bank data (2019 estimates). The U.S. consumer went from saving less than 4% of disposable income in 2007 to saving 7.5% in 2019. Canada went in the opposite direction. From a high of ~4.6% in 2009, savings rates have averaged ~3.6% over ten years and ended 2019 at 3.0%.

This debt will have to be repaid, and will be done so in a significantly devalued currency. Year to date the loonie has plunged 8% against the US dollar, with top currency forecasters expecting further declines. CIBC, which according to Bloomberg rankings had the most accurate forecast for the Canadian dollar in the first quarter, sees the loonie falling toward a four-year low in the coming months. “When you look at the Canadian dollar right now, it’s primarily a story of oil price pressures. We still don’t know how bad the impact is going to be in the real economy. But it’s going to be very very deep. We’re still very much beholden to political headlines, choppy headlines.”

Three Things I’m Watching:

  1. The loonie is poised to slip further, at least according to the top currency forecasters.

  2. We have liftoff! The Bank of Canada’s balance sheet has officially launched operation QE.

3.Canadian auto sales plunged 48% year-over-year in March as Coronavirus puts a dent on shopping plans.

Cheers,

Steve

PS: I will be hosting a live webinar with debt consultant Scott Terrio. Scott is on the front lines of managing the household debt bubble. We will discuss real life stories, and what he is seeing today as unemployment rises. Register HERE.

1 « J'aime »

Je ne veux pas rentrer dans les détails mais il y a de bonnes raisons de ne pas vouloir le donner à tout le monde, même si c’est fait progressivement.

La meilleure option est de tester tout le monde, fréquemment, et d’avoir les résultats en 5 minutes. On peut repartir tranquillement la machine économique avec la majorité de la population.

Google a sorti un rapport intéressant sur la mobilité :

J’ai une position d’environ 20% cash en ce moment. J’ai fait quelques bets mais je vais être patient pour les prochains. J’ai peur que beaucoup d’investisseurs se brûlent avant que ça reparte pour de vrai.

Viemed increases Q1 revenue guidance to $23.7-million

Viemed augmente les prévisions de revenus du premier trimestre à 23,7 millions de dollars

https://www.stockwatch.com/News/Item?bid=Z-C%3AVMD-2887879&symbol=VMD&region=C

2 « J'aime »

La compagnie fait son premier appel conférence à 11h30 aujourd’hui (maintenant) :

VERDE SECURES 48% GROSS MARGIN AND GROWS 344% IN 2019

CONFERENCE CALL DETAILS
The Company will hold a conference call on Wednesday April 8, 2020 at 11:30 am Eastern time
(8:30 am Pacific time) to discuss these results and provide an update. Subscribe at the
following link and receive the conference details by email.
Date: Wednesday, April 8, 2020
Time: 11:30 am Eastern Time (8:30 am Pacific time)
Subscription link: bit.ly/Q42019Results
The Company’s audited annual consolidated annual financial statements and related notes for
the year ended December 31, 2019 will be available to the public on SEDAR at www.sedar.com

CBDT - Empower Clinics

LE CEO est nul autre que Steven McAuley le CEO de Xpel, un titre bien aimé du forum.

CBDT est l’entreprise avec qui CANN a un JV aux États-Unis

J’pense que tu te trompes…le CEO est Ryan Pape depuis 2009.

Steven McAuley était CEO de 2007 à 2008 alors que la compagnie valait quelques sous et n’allait nul part.

Tu donnes du crédit à la mauvaise personne.

3 « J'aime »

La première fois que je me suis fait présenter la compagnie, ça m’a été présenté exactement comme ça. Après avoir fait des recherches, je me suis rendu compte que Steven McAuley a fait deux acquisitions absolument épouvantables chez Xpel et qu’il a été renvoyé en moins de deux ans après avoir amené la compagnie au bord de la faillite. C’est Ryan Pape (le CEO actuel) qui a redressé la compagnie depuis ce temps.

Si jamais c’est nécessaire que je le mentionne, je n’ai pas investi dans CBDT :stuck_out_tongue:

3 « J'aime »